You just read:

Celsion Presents Compelling Data at AACR 2016 Demonstrating Synergistic Anti-Cancer Effect of GEN-1 IL-12 Immunotherapy Plus Avastin® and Doxil®

News provided by

Celsion Corporation

19 Apr, 2016, 08:00 ET